Is CHMA or RYLD a better dividend investment in 2026?

CHMA currently yields 53.19% with a 5% 5-year dividend growth rate. RYLD yields 12.39% with 5% growth. The better choice depends on your goal: CHMA offers higher current income.

What is the dividend yield difference between CHMA and RYLD?

CHMA has a forward dividend yield of 53.19% ($2.00/share annually). RYLD yields 12.39% ($1.81/share annually). The yield gap is 40.80 percentage points.

Home › Compare › CHMA vs RYLD

CHMA vs RYLD: Dividend Comparison 2026

CHMA yields 53.19% · RYLD yields 12.39%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHMA wins by $418.6K in total portfolio value

INVESTMENT

TIME HORIZON10 years

CHMA

● Live price

53.19%

Share price

$3.76

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$463.9K

Annual income

$98,742.26

Full CHMA calculator →

RYLD

● Live price

12.39%

Share price

$14.64

Annual div

$1.81

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$45.3K

Annual income

$2,682.98

Full RYLD calculator →

Portfolio growth — CHMA vs RYLD

📍 CHMA pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHMA	RYLD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHMA + RYLD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHMA pays

RYLD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHMA

Annual income on $10K today (after 15% tax)

$4,521.28/yr

After 10yr DRIP, annual income (after tax)

$83,930.92/yr

RYLD

Annual income on $10K today (after 15% tax)

$1,053.44/yr

After 10yr DRIP, annual income (after tax)

$2,280.53/yr

At 15% tax rate, CHMA beats the other by $81,650.39/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHMA + RYLD for your $10,000?

CHMA: 50%RYLD: 50%

100% RYLD50/50100% CHMA

Portfolio after 10yr

$254.6K

Annual income

$50,712.62/yr

Blended yield

19.92%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHMA buys

RYLD buys

No recent congressional trades found for CHMA or RYLD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHMARYLD

Forward yield	53.19% ✓	12.39%
Annual dividend / share	$2.00 ✓	$1.81
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$463.9K ✓	$45.3K
Annual income after 10y	$98,742.26 ✓	$2,682.98
Total dividends collected	$375.4K ✓	$19.4K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CHMA vs RYLD ($10,000, DRIP)

Year	CHMA Portfolio	CHMA Income/yr	RYLD Portfolio	RYLD Income/yr	Gap
1← crossover	$16,019	$5,319.15	$11,939	$1,239.34	+$4.1K → CHMA
2	$25,104	$7,963.39	$14,158	$1,382.89	+$10.9K → CHMA
3	$38,524	$11,663.14	$16,682	$1,532.59	+$21.8K → CHMA
4	$57,948	$16,727.28	$19,537	$1,687.64	+$38.4K → CHMA
5	$85,520	$23,515.14	$22,752	$1,847.20	+$62.8K → CHMA
6	$123,939	$32,433.20	$26,355	$2,010.43	+$97.6K → CHMA
7	$176,544	$43,928.74	$30,376	$2,176.45	+$146.2K → CHMA
8	$247,382	$58,480.13	$34,847	$2,344.43	+$212.5K → CHMA
9	$341,283	$76,584.37	$39,800	$2,513.54	+$301.5K → CHMA
10	$463,915	$98,742.26	$45,269	$2,682.98	+$418.6K → CHMA

CHMA vs RYLD: Complete Analysis 2026

CHMA — Stock

Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.

Full CHMA Calculator →

RYLD — ETF

The Global X Russell 2000 Covered Call ETF (RYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe Russell 2000 BuyWrite Index.

Full RYLD Calculator →

📬

Get this CHMA vs RYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHMA vs SCHD CHMA vs JEPI CHMA vs O CHMA vs KO CHMA vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.